Study overturns dogma of cancer metabolism theory

by University of California, Los AngelesImage shows squamous cell skin cancer tumors with lactate production (a byproduct of glucose consumption) in purple. The tumor with lactate production bloc

Updated on: June 01,2024

Study overturns dogma of cancer metabolism theory

by University of California, Los AngelesImage shows squamous cell skin cancer tumors with lactate production (a byproduct of glucose consumption) in purple. The tumor with lactate production bloc

Updated on:June 01,2024

Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

by Sharita Forrest,University of Illinois at Urbana-ChampaignTargeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneousl

Updated on: May 27,2024

Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

by Sharita Forrest,University of Illinois at Urbana-ChampaignTargeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneousl

Updated on:May 27,2024

Researchers to investigate screening for prostate cancer using MRI—potentially replacing the PSA test

by Medical Research CouncilCredit: Medical Research CouncilA new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accur

Updated on: March 06,2024

Researchers to investigate screening for prostate cancer using MRI—potentially replacing the PSA test

by Medical Research CouncilCredit: Medical Research CouncilA new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accur

Updated on:March 06,2024

New review on p53 biology and reactivation in blood cancers

byKarolinska InstitutetA simplified scheme of p53 regulation in cells upon stress and the drugs currently evaluated in clinical trials for p53 reactivation for improved therapy in MDS and AML. C

Updated on: March 30,2024

New review on p53 biology and reactivation in blood cancers

byKarolinska InstitutetA simplified scheme of p53 regulation in cells upon stress and the drugs currently evaluated in clinical trials for p53 reactivation for improved therapy in MDS and AML. C

Updated on:March 30,2024

Leukemia, lymphoma squarely in sights of new class of drugs

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: CC0 Public DomainUT Health San Antonio researchers, working with collaborators at the University of Florida, have d

Updated on: March 08,2024

Leukemia, lymphoma squarely in sights of new class of drugs

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: CC0 Public DomainUT Health San Antonio researchers, working with collaborators at the University of Florida, have d

Updated on:March 08,2024

Target discovered for the treatment of pancreatic cancer

byKiel UniversityAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA team at the Institute of Biochemistry at Kiel University has found a

Updated on: July 05,2024

Target discovered for the treatment of pancreatic cancer

byKiel UniversityAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA team at the Institute of Biochemistry at Kiel University has found a

Updated on:July 05,2024

Researchers develop novel gold-nanocluster-based tumor radiodynamic therapy

by Zhang Nannan,Chinese Academy of SciencesGold-nanocluster-based radiodynamic therapy. Credit: IGDBRadiotherapy (RT) is a primary method of tumor treatment. However, in clinical practice, radio

Updated on: February 01,2024

Researchers develop novel gold-nanocluster-based tumor radiodynamic therapy

by Zhang Nannan,Chinese Academy of SciencesGold-nanocluster-based radiodynamic therapy. Credit: IGDBRadiotherapy (RT) is a primary method of tumor treatment. However, in clinical practice, radio

Updated on:February 01,2024

Survivorship standards help address the distinct needs of adult cancer survivors

byAmerican College of SurgeonsCredit: Thirdman from PexelsWith the number of adult cancer survivors in the United States expected to reach 23 million by 2032, the long-term needs of this populat

Updated on: July 05,2024

Survivorship standards help address the distinct needs of adult cancer survivors

byAmerican College of SurgeonsCredit: Thirdman from PexelsWith the number of adult cancer survivors in the United States expected to reach 23 million by 2032, the long-term needs of this populat

Updated on:July 05,2024

Discovery of new mechanism explains how ovarian cancer disables immune cells

byWeill Cornell Medical CollegeThis confocal micrograph shows two proteins,TAGLN2 (green) and FABP5 (red), are found together (yellow) on the surfaces of T cells, enabling the cells to pick up l

Updated on: November 11,2024

Discovery of new mechanism explains how ovarian cancer disables immune cells

byWeill Cornell Medical CollegeThis confocal micrograph shows two proteins,TAGLN2 (green) and FABP5 (red), are found together (yellow) on the surfaces of T cells, enabling the cells to pick up l

Updated on:November 11,2024

New method eradicates deadly brain tumors by 'starving' them of energy source

byTel Aviv UniversityDr. Lior Mayo and students. Credit: Tel Aviv UniversityA groundbreaking study at Tel Aviv University effectively eradicated glioblastoma, a highly lethal type of brain cance

Updated on: January 13,2024

New method eradicates deadly brain tumors by 'starving' them of energy source

byTel Aviv UniversityDr. Lior Mayo and students. Credit: Tel Aviv UniversityA groundbreaking study at Tel Aviv University effectively eradicated glioblastoma, a highly lethal type of brain cance

Updated on:January 13,2024

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on: March 30,2024

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on:March 30,2024

HPV immunization program cuts pre-cancer rates by more than half

by University of British ColumbiaGardasil vaccine and box. Image: WikipediaA school-based human papillomavirus (HPV) immunization program in British Columbia, Canada, is dramatically reducing rat

Updated on: March 01,2024

HPV immunization program cuts pre-cancer rates by more than half

by University of British ColumbiaGardasil vaccine and box. Image: WikipediaA school-based human papillomavirus (HPV) immunization program in British Columbia, Canada, is dramatically reducing rat

Updated on:March 01,2024